Live updates

US nurse shares hug with Obama after surviving Ebola

One of the two US nurses who have survived the Ebola virus after contracting the disease from a dying patient has shared a hug with Barack Obama after meeting the president at the White House.

Nina Pham had been transferred to a specialist treatment centre in Maryland, near Washington DC, after initially being treated in Texas.

Ms Pham's meeting with Mr Obama came hours after she was released from hospital after being publicly declared virus free.

Her colleague Amber Vinson was also declared free of Ebola earlier today after receiving treatment in Atlanta.

'Smart drugs' worth £200,000 seized in Midlands raid

A batch of so-called smart drugs worth £200,000 - including substances never tested on humans - has been found in the largest seizure of apparent intelligence-enhancing drugs in the UK.

Around 20,000 units of 13 different "cognitive enhancers" were taken in the raid on a lock-up in the Midlands after a tip off via Norwegian customs.

The drugs have been targeted at students because they aid concentration and ward off sleep.

A spokesperson for the medicines regulator that carried out the raid confirmed a man had been cautioned. He added:

This is a recent and very worrying trend. The idea that people are willing to put their overall health at risk in order to attempt to get an intellectual edge over others is deeply troubling.

– Alastair Jeffrey, the Medicines and Healthcare Products Regulatory Agency's head of enforcement

While it would be legal to possess the seized drugs, it is illegal to sell or supply prescription-only or unlicensed medicines.

Advertisement

Second US nurse Amber Vinson declared Ebola free

US nurse Amber Vinson has followed her colleague Nina Pham in being declared free of the Ebola virus, after the pair contracted the disease while treating a dying patient at their Dallas hospital.

Amber Vinson, 29, was the second nurse to contract the Ebola virus at her Dallas hospital. Credit: Akron Public Schools/NBC News

Ms Vinson's status was confirmed by the Atlanta medical centre where she had been receiving treatment after a transfer from a Texas hospital.

Vinson's fellow nurse Pham was earlier declared virus free after receiving treatment in Maryland.

Human safety trials sped up to get out Ebola vaccines

Drugmakers have pledged to work together to speed up Ebola safety trials in human volunteers in a bid to produce an estimated 200,000 doses of experimental vaccines by the middle of 2015.

Two leading vaccine candidates, from GlaxoSmithKline and NewLink Genetics, are in human clinical trials while another five experimental vaccines are set to begin clinical trials next year.

A researcher holds a package of an experimental candidate vaccine against the Ebola virus at the University hospital in Geneva. Credit: Reuters/Mathilde Missioneiro/WHO

High risk groups, including frontline health workers in West Africa, are front of the queue to receive the vaccines by early next year.

"Vaccines are not a magic bullet, but when ready they may be a good part of the effort to turn the tide against the epidemic," the WHO's Marie-Paule Kieny said after a meeting of industry executives, global health experts, drug regulators and funders in Geneva.

Advertisement

Resources pour in, but the cost of fighting Ebola is huge

While money and resources continue to pour into the areas worst affected by the Ebola outbreak, the costs of fighting the disease remain huge.

Hussein Ibrahim from the International Medical Corps said it cost around £800,000 to run one clinic in the capital of Sierra Leone, Freetown.

Mr Ibrahim also said running a 100-bed facility needed 250 staff so the IMC needs volunteers as well as money.

ITV News Correspondent Dan Rivers reports from Sierra Leone.

Millions of Ebola vaccines 'ready by end of 2015'

Millions of doses of an Ebola vaccine will be ready by the end of 2015, World Health Organisation (WHO) has said.

The organisation said "money will not be an issue" when developing and distributing vaccines against the deadly virus.

Potential manufacturers have committed to ensuring vaccines are sold at affordable prices, a WHO official added.

Load more updates